Sarah Nikiforow

Sarah Nikiforow serves as Medical Director of Cellular Therapy at Dana-Farber Cancer Institute, overseeing the clinical operations of cell therapy manufacturing from apheresis collection through product administration. Her work has established best practices for patient management during the manufacturing waiting period and optimized apheresis collection protocols for improved manufacturing outcomes. She has contributed to national guidelines for immune effector cell therapy administration and toxicity management.